No summary available
No summary available
No summary available
No summary available
No summary available
If you would like to send a message to the board of directors, please use the contact form or email board@aappfoundation.org.
Download the CPNP Foundation's Strategic Plan
Welcome to the AAPP Foundation!
The Clozapine in Practice toolkit has recently been updated to reflect the discontinuation of the REMS and to describe current information on monitoring guidelines. A special thanks to lead author Jonathan Leung and co-authors Robin Hieber, Jenna Stearns, and Greg Deardorff for their work to update this important toolkit.
Long-time AAPP member and the current AAPP Foundation President-Elect, Clayton English, PharmD, BCPS, BCPP, BCGP, FAAPP, is part of a team of SoP faculty researchers at the University of Washington School of Pharmacy that has been awarded a $200,000 Tier 3 pilot research grant from the UW Population Health Initiative. The team’s work aims to address the rise in opioid overdose deaths, increasingly driven by fentanyl. This work is vital to public health. Help us congratulate Dr. English!
Long-time AAPP member and the current AAPP Foundation President, Clayton English, PharmD, BCPS, BCPP, BCGP, FAAPP, is part of a team of SoP faculty researchers at the University of Washington School of Pharmacy that has been awarded a $200,000 Tier 3 pilot research grant from the UW Population Health Initiative. The team’s work aims to address the rise in opioid overdose deaths, increasingly driven by fentanyl. This work is vital to public health. Help us congratulate Dr. English!
LAI Pocket Guide: Aristada®
LAI Pocket Guide: Abilify Maintena® (Aripiprazole Monohydrate)
LAI Pocket Guide: Haloperidol decanoate
LAI Pocket Guide: Fluphenazine decanoate
The ultimate goal is that every patient with a psychiatric disorder, including substance use disorders, will have their medication therapy reviewed, optimized, and managed by a psychiatric pharmacist as part of a psychotropic stewardship team. In short, intentional efforts to have a Board Certified Psychiatric Pharmacist (BCPP) provide Comprehensive Medication Management (CMM) services to patients with psychiatric disorders will improve access, outcomes, and cost.
AAPP envisions a world where all individuals living with mental illness receive safe, appropriate, and effective treatment. To achieve that, it is important to promote practices that reflect the best current evidence available. Thus, over time, all content will either be updated or removed from the web site.
What you need to know about stimulant versus non-stimulant treatment options for ADHD.
What you need to know about dose adjustments.
What you need to know about hwo to take your medication.
What you need to know about measuring response to medications.
Carla Cobb, PharmD, BCPP
Access to specialized mental health and crisis professionals for children and adolescents is severely limited contributing to the growing youth mental health crisis. This issue brief outlines how psychiatric pharmacists are part of the solution to achieve both early intervention and optimization of medications to improve outcomes.
What you need to know about mental health apps.
What you need to know about self-rated scales.